Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a Locations section with the Texas site and updated to revision v3.3.3; removed the Texas Locations entry and the HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-12-23T12:35:44.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; this is a minor metadata change and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice and associated operating status information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T15:06:18.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page; the study overview, objectives, eligibility criteria, and plan appear unchanged. Any minor formatting differences are not considered impactful.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:17.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:39:43.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    - Terminology updated: 'Clear cell renal carcinoma' replaced with 'Clear cell carcinoma of kidney'. - Version bumped from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:27:08.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.